Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Mallinckrodt
Medtronic
Dow
Express Scripts
McKesson

Last Updated: December 3, 2022

CLINICAL TRIALS PROFILE FOR NEOMYCIN SULFATE


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


All Clinical Trials for Neomycin Sulfate

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00534391 ↗ Comparison of Combination Antibiotics Eyedrop to Artificial Tear in Hordeolum After Incision and Curettage Unknown status Chulalongkorn University Phase 3 2007-09-01 To compare the effectiveness of combined antibiotic ophthalmic solution (neomycin sulfate, polymyxin B sulfate and gramicidin) with placebo (artificial tear) in the treatment of hordeolum after incision and curettage
NCT00857688 ↗ Efficacy of the Combination Bismuth + Neomycin + Procaine in the Treatment of Recurrent Aphthous Ulceration Completed Azidus Brasil Phase 3 2011-05-01 To evaluate the efficacy of the product Bismu-Jet ® (bismuth tartrate and sodium, neomycin sulfate and procaine hydrochloride) produced by EMS S / A compared to placebo in reducing the signs and symptoms resulting from UAR in patients of both sexes, with age over 12 years.
NCT01227863 ↗ Efficacy Maxinom® And Maxitrol® in Reducing The Signs And Symptoms Of Acute Bacterial Conjunctivitis Unknown status Azidus Brasil Phase 3 2011-02-01 The primary objective of this study is to evaluate, through clinical parameters, the effectiveness of your medicine topic Maxinom ® (dexamethasone, neomycin and polymyxin B - Union Chemicals), comparing it to the topical medication Maxitrol ® (dexamethasone, neomycin and polymyxin B - Alcon ) by the percentage of improvement (sustained response rate) at the end of treatment, among the products studied.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Neomycin Sulfate

Condition Name

Condition Name for Neomycin Sulfate
Intervention Trials
Rabies Human 1
Suture Strabismus Surgery 1
Tinea 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Neomycin Sulfate
Intervention Trials
Conjunctivitis, Bacterial 1
Tinea 1
Conjunctivitis 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Neomycin Sulfate

Trials by Country

Trials by Country for Neomycin Sulfate
Location Trials
Brazil 6
United States 3
Israel 1
Thailand 1
France 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Neomycin Sulfate
Location Trials
Georgia 1
Florida 1
New Jersey 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Neomycin Sulfate

Clinical Trial Phase

Clinical Trial Phase for Neomycin Sulfate
Clinical Trial Phase Trials
Phase 4 3
Phase 3 4
Phase 2 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Neomycin Sulfate
Clinical Trial Phase Trials
Completed 4
Unknown status 3
Not yet recruiting 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Neomycin Sulfate

Sponsor Name

Sponsor Name for Neomycin Sulfate
Sponsor Trials
Azidus Brasil 2
Stephen Harbarth 1
Ache Laboratorios Farmaceuticos S.A. 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Neomycin Sulfate
Sponsor Trials
Other 11
Industry 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
AstraZeneca
McKesson
Colorcon
Moodys
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.